CNN

Zealand Pharma presents elaborated results on the use of regular human insulin delivered by V-Go® in older adults with type 2 diabetes, at the 80th Scientific Sessions of the ...

In older adults with type 2 diabetes, use of human regular insulin delivered by V-Go ® demonstrated similar glycemic control with no increased hypoglycemia risk compared to use of rapid acting insulin ...
Business Insider

Valeritas Announces Milestone of 20 Million V-Go® Insulin Delivery Devices Sold

BRIDGEWATER, N.J., June 24, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go ® Wearable Insulin Delivery device, announced today it ...
Business Insider

Valeritas to Present Results of the Prospective Pragmatic Multicenter Clinical Trial of V-Go® Wearable Insulin Delivery Device to the European Diabetes Community

Study demonstrated Clinical Efficacy and Lower Total Daily Insulin Dose in Patients with Type 2 Diabetes Poster Presentation on September 13 during the European Association for the Study of Diabetes ...